Oakbrook Investments’s NuVasive, Inc. NUVA Stock Holding History

Oakbrook Investments’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,900	Closed	-$204K	–	633
2018 Q1	$204K	Buy	+3,900	New	+$198K	0.01%	551
2016 Q4	–	Sell	-4,100	Closed	-$273K	–	598
2016 Q3	$273K	Buy	+4,100	New	+$261K	0.02%	469

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oakbrook Investments's NUVA Position: Q2 2018 in Review

Oakbrook Investments sold out of NuVasive, Inc. (NUVA) in Q2 2018, closing a stake of 3,900 shares — an estimated $204K sold.

Oakbrook Investments first reported a position in NUVA in Q3 2016 and held it in 2 quarters. The position peaked at $273K in Q3 2016. 277 funds tracked by Wall St. Rank hold NUVA as of Q2 2018.

Oakbrook Investments reported no remaining NuVasive, Inc. position as of Q2 2018 after selling out during the quarter.
Oakbrook Investments sold 3,900 NuVasive, Inc. shares in Q2 2018, an estimated $204K.
Oakbrook Investments first reported a position in NuVasive, Inc. in Q3 2016 and held it in 2 quarters.
Oakbrook Investments's NuVasive, Inc. position peaked at $273K in Q3 2016.
277 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2018.

Based on Oakbrook Investments's 13F filing for Q2 2018, filed 18 Jul 2018.